Eli Lilly Covid-19 Antibody Treatment Trial Is Paused Due To ‘Potential Safety Concern’

President Trump has promoted the company’s antibody treatment in recent videos.

Read the full post on Forbes - Healthcare

Elana Lyn Gross, Forbes Staff